NCT04820959View on ClinicalTrials.gov

Validation of New Therapeutic Targets to Prevent Collagen Accumulation During Cardiac Fibrosis: Procollagen C-proteinase Enhancers

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 4, 2020

Primary Completion Date

July 7, 2022

Study Completion Date

July 7, 2022

Conditions
ValvulopathyHeart SurgeryProcollagen C-Proteinase Enhancers
Interventions
BIOLOGICAL

Biopsies

"Three endomyocardial intraoperative biopsies were performed on the left ventricle.~Resection of the left atrium in the event of atrial fibrillation."

BIOLOGICAL

Blood sampling

Pre-operative blood sampling

Trial Locations (1)

21000

CHU Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04820959 - Validation of New Therapeutic Targets to Prevent Collagen Accumulation During Cardiac Fibrosis: Procollagen C-proteinase Enhancers | Biotech Hunter | Biotech Hunter